» Articles » PMID: 2242327

The Pathophysiology of Sandimmune (cyclosporine) in Man and Animals

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1990 Sep 1
PMID 2242327
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Part I: The side-effects of Sandimmune that have been of most significance clinically are renal dysfunction, renal vascular damage and arterial hypertension. To examine the nature and the origin of such effects, the actions of Sandimmune on the renal tubule, the renal vessels and systemic vessels have been analyzed. To evaluate whether common vasoconstrictory systems may be involved, changes in the renin-angiotensin-aldosterone system and prostaglandin-thromboxane system have been assessed. Comparison between animal and human data obtained in vivo and in vitro shows the actions of Sandimmune on the renal tubule to be modest and involve only a few specific effects. The major action of Sandimmune is on the vessels, vasoconstriction being the major cause of renal dysfunction and also the cause of arterial hypertension. Neither the circulating renin-angiotension-aldosterone system nor the prostaglandin-thromboxane system is clearly responsible for vasoconstriction. Although not itself a vasoconstrictor, Sandimmune seems to modulate the constrictory and dilatory response to other agents in several vascular beds.

Citing Articles

HNF4alpha dysfunction as a molecular rational for cyclosporine induced hypertension.

Niehof M, Borlak J PLoS One. 2011; 6(1):e16319.

PMID: 21298017 PMC: 3029342. DOI: 10.1371/journal.pone.0016319.


Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years.

Kranz B, Vester U, Buscher R, Wingen A, Hoyer P Pediatr Nephrol. 2008; 23(4):581-6.

PMID: 18197423 PMC: 2259257. DOI: 10.1007/s00467-007-0709-6.


Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury.

Josephine A, Veena C, Amudha G, Preetha S, Varalakshmi P Mol Cell Biochem. 2006; 287(1-2):101-8.

PMID: 16703458 DOI: 10.1007/s11010-005-9081-7.


Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?.

Fricker G, Fahr A Yale J Biol Med. 1997; 70(4):379-90.

PMID: 9626758 PMC: 2589335.


Chronic rejection and late renal allograft dysfunction.

Laine J, Holmberg C, Hayry P Pediatr Nephrol. 1996; 10(2):221-9.

PMID: 8703719 DOI: 10.1007/BF00862088.


References
1.
Erman A, Rosenfeld J . The role of eicosanoids in cyclosporine nephrotoxicity in the rat. Biochem Pharmacol. 1989; 38(13):2153-7. DOI: 10.1016/0006-2952(89)90070-1. View

2.
Laskow D, Curtis J, Luke R, Jones P, Barber H, Deierhoi M . Cyclosporine impairs the renal response to volume depletion. Transplant Proc. 1988; 20(3 Suppl 3):568-71. View

3.
BAXTER C, Duggin G, HORVATH J, Hall B, Tiller D . Cyclosporin A and renal prostaglandin biosynthesis. Res Commun Chem Pathol Pharmacol. 1984; 45(1):69-80. View

4.
Batlle D, Gutterman C, Tarka J, Prasad R . Effect of short-term cyclosporine A administration on urinary acidification. Clin Nephrol. 1986; 25 Suppl 1:S62-9. View

5.
BAXTER C, Duggin G, Willis N, Hall B, HORVATH J, Tiller D . Cyclosporin A-induced increases in renin storage and release. Res Commun Chem Pathol Pharmacol. 1982; 37(2):305-12. View